Norris, J. D., Ellison, S. J., Baker, J. G., Stagg, D. B., Wardell, S. E., Park, S., . . . McDonnell, D. P. (2017). Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer. J Clin Invest.
Chicago Style CitationNorris, John D., et al. "Androgen Receptor Antagonism Drives Cytochrome P450 17A1 Inhibitor Efficacy in Prostate Cancer." J Clin Invest 2017.
Cita MLANorris, John D., et al. "Androgen Receptor Antagonism Drives Cytochrome P450 17A1 Inhibitor Efficacy in Prostate Cancer." J Clin Invest 2017.
Atenció: Aquestes cites poden no estar 100% correctes.